A B-cell developmental gene regulatory network is activated in infant AML
Infant Acute Myeloid Leukemia (AML) is a poorly-addressed, heterogeneous malignancy distinguished by surprisingly few mutations per patient but accompanied by myriad age-specific translocations. These characteristics make treatment of infant AML challenging. While infant AML is a relatively rare dis...
Saved in:
Main Authors: | Hamid Bolouri, Rhonda Ries, Laura Pardo, Tiffany Hylkema, Wanding Zhou, Jenny L. Smith, Amanda Leonti, Michael Loken, Jason E. Farrar, Timothy J. Triche, Soheil Meshinchi |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d13c5f80eaca472491942928dac038df |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A B-cell developmental gene regulatory network is activated in infant AML.
by: Hamid Bolouri, et al.
Published: (2021) -
TARGETED THERAPY IN AML TREATMENT
by: Giovanni Martinelli
Published: (2021) -
Developmental change of the biorbital angle in normal Japanese infants
by: Yagasaki T, et al.
Published: (2018) -
Cis-regulatory timers for developmental gene expression.
by: Lionel Christiaen
Published: (2013) -
Developmental changes in social attention and oxytocin levels in infants and children
by: Minaho Nishizato, et al.
Published: (2017)